SEC Form 4 · accession 0001127602-19-008344
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 25, 2019
Accepted (ET)
Feb 26, 2019 · 3:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 25, 2019 | S | 247 | $145.96 | D | 286,397 | D | |
| Common Stock | Feb 25, 2019 | S | 253 | $145.965 | D | 286,144 | D | |
| Common Stock | Feb 25, 2019 | S | 400 | $145.98 | D | 285,744 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $145.985 | D | 285,544 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $146.00 | D | 285,444 | D | |
| Common Stock | Feb 25, 2019 | S | 500 | $146.01 | D | 284,944 | D | |
| Common Stock | Feb 25, 2019 | S | 300 | $146.02 | D | 284,644 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $146.03 | D | 284,444 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $146.05 | D | 284,244 | D | |
| Common Stock | Feb 25, 2019 | S | 400 | $146.065 | D | 283,844 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $146.14 | D | 283,744 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $146.195 | D | 283,644 | D | |
| Common Stock | Feb 26, 2019 | F | 2,273 | $145.31 | D | 281,371 | D | |
| Common Stock | holding | — | — | — | 18,390 | I | 2017 GRAT | |
| Common Stock | holding | — | — | — | 25,000 | I | 2018 GRAT | |
| Common Stock | holding | — | — | — | 340 | I | By Trust | |
| Common Stock | holding | — | — | — | 10,000 | I | Held By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.